Philadelphia Pharmaceuticals Company (ASE:PHIL)
2.000
0.00 (0.00%)
At close: Oct 15, 2026
| Market Cap | 15.00M +29.0% |
| Revenue (ttm) | 8.97M -2.3% |
| Net Income | 1.06M +15.9% |
| EPS | 0.14 +15.9% |
| Shares Out | 7.50M |
| PE Ratio | 14.15 |
| Forward PE | n/a |
| Dividend | 0.07 (3.50%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 10 |
| Open | 2.000 |
| Previous Close | n/a |
| Day's Range | 2.000 - 2.000 |
| 52-Week Range | 1.500 - 2.010 |
| Beta | -0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 29, 2026 |